HCA Healthcare, Inc.

NYSE: HCA·Nashville, Tennessee·

Price
$511.78
Base IV
$431.51

Valuation snapshot

Above base case

At $511.78, the price sits between our base case ($431.51) and bull case ($688.09).

Values per share, from an .

No growth
…
Loading earnings power
Base case
$431.51
84% of the price · range $205.16–$688.09
Price vs base case
19% above
$511.78 against $431.51
Base casevalued by DCF
Price vs base
Priceclose 11‑16

The price has risen 7.0% since this valuation was struck on 2026-10-30, so some of the gap opened up after these figures were set.

Whisker on the base case runs bear $205.16 to bull $688.09. Values per share.

Price against each value

Bear case
$205.16
Price 149% above
No growth
…
—
Base case
$431.51
Price 19% above
Researched bygpt-6-sol
Valuation Oct 30, 2026 · Price as of Nov 16, 2026How we got here

What does HCA Healthcare do?

HCA Healthcare provides patients with medical and surgical services through a network of hospitals, ambulatory surgery centers, and urgent care facilities.

It brought in $78.7B of sales in the 12 months to Sep 2026.

Led by Samuel N. Hazen, Chief Executive Officer since 2019. HCA Healthcare, Inc. Form 10-K for the Fiscal Year Ended December 31, 2024

Industry
Healthcare
Based in
Nashville, Tennessee
Trades on
NYSE as HCA

Here is where each dollar a customer pays ends up. Out of every $1 of sales in the 12 months to Sep 2026, about 9¢ was left as profit after every cost, interest and tax. The biggest cost is everything else, including interest, 87¢ of every dollar.

  • Admin costs1¢
  • Everything else, including interest87¢
  • Tax3¢
  • Other items after tax1¢
  • Left as profit9¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays HCA Healthcare, and for what?

HCA operates hospitals and outpatient facilities that provide medical, behavioral health, surgery, emergency and other care. It earns revenue by treating patients and receiving payment from government programs, health insurers and patients.

Its payers include Medicare and Medicaid programs, managed care plans and private insurers, international insurers, and patients who pay directly.

  • Medicare

    15%

    Payments from the federal Medicare program for patient care.

  • Managed Medicare

    18%

    Payments through private health plans that provide Medicare benefits.

  • Medicaid

    8%

    Payments from state and federal Medicaid programs.

  • Managed Medicaid

    5%

    Payments through private plans that provide Medicaid coverage.

  • Managed care and other insurers

    49%

    Payments from private health insurers and managed care plans, excluding managed Medicare and managed Medicaid.

  • International and other

    6%

    Payments from international insurers and other sources, including uninsured patients.

Share of the latest fiscal year's sales, as the company reports it.

Where its work physically happens, beyond headquarters:

  • Texas hospital portfolio (Houston anchor market) — Houston, United States. Texas is HCA's largest state, with 55 hospitals and 14,595 licensed beds at Dec. 31, 2025; together with Florida it produced 51% of 2025 consolidated revenue, so local conditions there move company results.
  • Florida hospital portfolio (West Florida / Tampa Bay market) — Tampa, United States. Florida's 47 hospitals and 13,384 licensed beds are HCA's second-largest concentration, and the 10-K says the Florida-Texas weighting makes results particularly sensitive to those states' economies, payer mix and hurricanes.
  • Virginia hospital portfolio (Richmond market) — Richmond, United States. Virginia's 11 hospitals and 3,359 licensed beds make it HCA's third-largest state by bed capacity, a key part of revenue outside Florida and Texas.
  • HCA HealthONE Colorado (Denver market) — Denver, United States. Colorado's 7 hospitals hold 2,625 licensed beds, a high number of beds per hospital that marks Denver as a dense, high-acuity HCA market.
  • North Carolina hospital portfolio (Mission Health, Asheville) — Asheville, United States. North Carolina's 7 hospitals and 1,292 licensed beds come mainly from the Mission Health acquisition, a growth market that also carries regulatory and reputational exposure.
See them on the globe

HCA Healthcare 2025 Form 10-K

How is the business doing?

Sales grew from $51.5B in 2020 to $75.6B in 2025, about 8% a year.

After paying for its upkeep and new investment, it had $6B of cash to spare in the 12 months to Sep 2026.

Sales$75.6B
20172025
Free cash flow$7.7B
20172025
Each bar is one fiscal year (2017–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

HCA says it is committed to caring for people and improving human life.

“Above all else, we are committed to the care and improvement of human life.”

Who We Are

Who is responsible for the plan?

  • Samuel N. HazenChief Executive Officer

    Oversees the enterprise strategy, management, and operational administration across HCA Healthcare's network of hospitals and healthcare facilities. HCA Healthcare generates revenue through the provision of inpatient and outpatient healthcare services across its acute care hospitals, surgery centers, and clinics.

  • Jon M. FosterExecutive Vice President and Chief Operating Officer

    Oversees healthcare operations, hospital administration, and service delivery across the company's operating groups and divisions. Operational management of acute care hospitals and outpatient networks directly delivers patient care services that generate the company's operating revenue.

  • Chad J. WassermanSenior Vice President and Chief Information Officer

    Oversees global information technology strategy, infrastructure, data engineering, software systems, and digital clinical applications across the enterprise. Information technology systems and clinical software support daily healthcare delivery, patient care coordination, and billing across the company's facilities.

Roles checked November 14, 2026.

What management says it is working on now:

  • Grow in existing markets

    HCA plans to expand local networks, recruit physicians and develop services such as cardiology, neurology, oncology and women’s health.

    HCA Healthcare 2025 Form 10-K
  • Improve care and operations

    The company says it is working to improve patient safety, clinical quality, satisfaction and cost efficiency across its facilities.

    HCA Healthcare 2025 Form 10-K
  • Recruit and retain healthcare workers

    HCA is investing in hiring and keeping physicians and other healthcare professionals to meet demand for care.

    HCA Healthcare 2025 Form 10-K
  • Expand outpatient access

    HCA is developing outpatient facilities and care networks, including surgery centers, urgent care clinics, imaging centers, home health and hospice services.

    HCA Healthcare 2025 Form 10-K
  • Develop digital and AI capabilities

    HCA says it is deploying digital and AI tools to support clinical decisions, simplify workflows, coordinate care and improve efficiency, with privacy and security controls.

    HCA Healthcare 2025 Form 10-K
Revenue, 2026
$77.0 billion to $79.5 billion
HCA Healthcare Reports Second Quarter 2026 Results
Adjusted EBITDA, 2026
$15.4 billion to $16.1 billion
HCA Healthcare Reports Second Quarter 2026 Results
Net income attributable to HCA Healthcare, 2026
$6.3 billion to $6.7 billion
HCA Healthcare Reports Second Quarter 2026 Results
Diluted earnings per share, 2026
$28.70 to $30.50
HCA Healthcare Reports Second Quarter 2026 Results
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is slowing. In Q3 2026 it sold 4% more than a year earlier. The year before, quarters averaged 7%.

Since Oct 2026 the share price has risen 11%, from $459.40 to $511.78.

Bull $688.09Base $431.51Bear $205.16Oct 22Nov 16 · $511.78
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start October 22, 2026.

Recently

Coming up

  • By December 31, 2026; states may implement sooner

    Medicaid eligibility work requirements

    Federal law requires states to comply with new Medicaid work or community engagement requirements for some adults, which may affect enrollment and HCA’s payer mix.

    HCA Healthcare 2025 Form 10-K
  • For redeterminations scheduled on or after December 31, 2026

    Medicaid eligibility redeterminations

    More frequent eligibility checks for adults in Medicaid expansion states could change the number of people covered and the mix of patients paying for HCA’s services.

    HCA Healthcare 2025 Form 10-K
  • Started in 2026; a larger reduction may begin in 2027

    Medicare outpatient payment changes

    Medicare began applying a 0.5% annual reduction to outpatient payment rates in 2026 to offset past payments related to a drug pricing policy; HCA says CMS may accelerate the reduction.

    HCA Healthcare 2025 Form 10-K
  • Three-year phase-out beginning in 2026

    Medicare inpatient-only list phase-out

    Medicare is phasing out its list of procedures covered only in inpatient settings, making more procedures eligible for outpatient care and potentially shifting where HCA provides them.

    HCA Healthcare 2025 Form 10-K

Our own estimate moved too: the base case went from $306.83 to $431.51 a share between our last two valuations. The biggest reason: Q3 capital spending as a share of revenue moved from an unreported prior value to 6.8%, as reported in HCA Q3 2026 results.

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Changes to government healthcare funding

    Medicare and Medicaid policy changes can reduce payments or change who qualifies for coverage. HCA says recent federal law may lower Medicaid enrollment and funding, while rules for state payment programs remain uncertain.

    From the company's own filingsWould hit how fast sales growHCA Healthcare 2025 Form 10-K

  2. More patients without insurance

    If more patients lack coverage or owe larger deductibles and copayments, HCA may have difficulty collecting payment for care. HCA reported increased uninsured admissions in 2025 and said collection challenges may continue.

    From the company's own filingsWould hit how fast sales growHCA Healthcare 2025 Form 10-K

  3. Staffing and physician shortages

    Competition for nurses, physicians and other healthcare workers can raise labor costs or limit how many patients HCA can serve. Losing physicians or struggling to recruit them could also reduce admissions and growth.

    From the company's own filingsWould hit how much of each sale it keepsHCA Healthcare 2025 Form 10-K

  4. Cybersecurity and system interruptions

    A cyberattack or technology failure at HCA or a vendor could disrupt care, expose patient information, create legal costs or damage trust. HCA also says changes to clinical systems and AI tools may be difficult to implement safely and effectively.

    From the company's own filingsWould hit how much of each sale it keepsHCA Healthcare 2025 Form 10-K

  5. Significant debt

    HCA reported $46.5 billion of debt at year-end 2025. Interest costs, refinancing difficulties or limits in its debt agreements could reduce cash available for operations and investment.

    From the company's own filingsWould hit how much it has to reinvestHCA Healthcare 2025 Form 10-K

  6. Competition and changes in care settings

    Hospitals compete with other providers for patients, and insurers may steer procedures to lower-cost settings. Medicare’s expansion of procedures eligible for outpatient surgery centers could shift some care away from HCA hospitals.

    From the company's own filingsWould hit how fast sales growHCA Healthcare 2025 Form 10-K

  7. Q3 2026 revenue growth of 0.036 was below full-year 2025 growth of about 0.071.

    From our researchWould hit how fast sales growHCA Q3 2026 results

Is it a good business?

It bought back shares: the count fell 8.0% in a year, so each remaining share owns a slightly bigger slice.

It owes $49.6B more than it holds in cash. An operating-profit comparison is unavailable from the published quarters.

What might it be worth?

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $511.78. Our put its value between $205.16 and $688.09, with $431.51 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $205.16

After a slower third quarter, this scenario assumes HCA keeps growing, but more slowly, while caring for more patients whose bills bring in less money.

Base case, $431.51

HCA's patient numbers keep rising after a slower third quarter, while revenue and earnings grow at a steadier pace than they did in 2025.

Bull case, $688.09

Despite slower sales growth in the latest quarter, this scenario assumes more patients and better payment from insured patients help HCA regain much of its earlier momentum.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects more than we do.Price above value: 19%

For HCA Healthcare to be worth today's $511.78, sales would need to grow about 7.1% a year. We assume 4.4%. Over the last 5 years, sales grew 6.3% a year.

−2%0%+2%+4%+6%+8%We assume 4.4%Past 5 yrs 6.3%Price needs 7.1%

Or, if sales grow 4.4% as we assume, the price works with a profit margin of 16.8% (we assume 15.0%).

Keep in mind: this is one way to read the price. Investors might be expecting other things, like higher profits or lower risk.

Do you think sales can grow 7.1% a year?

Try your own numbers

We're moderately sure of this range: it scores 53 out of 100 on our checks. The weakest point is terminal-value dependency.

Test the assumptions

Our base value of $431.51 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average4.4%
  • Operating margin15.0%
  • Long-term growth rate2.5%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$431.51 -15.7%

Build